Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Horizon Pharma submits NDA for Lodotra to FDA

Oct. 3, 2011

Abbott Japan and Eisai set to launch new adalimumab formulation

Sep. 28, 2011

Synthesis and activity of novel IRAK-4 inhibitors described

Sep. 27, 2011

Novel glucocorticoid receptor modulators may have fewer side effects than steroids

Sep. 23, 2011

Sanofi transfers Hyalgan rights back to Fidia Farmaceutici

Sep. 20, 2011

Mitsubishi Tanabe and Janssen to market Simponi in Japan

Sep. 16, 2011

Single-dose NeoVisc approved for sale in Europe

Sep. 16, 2011

Pfizer reports pivotal data on tofacitinib in rheumatoid arthritis

Sep. 16, 2011

Small-molecule DMART ameliorates SLE-like symptoms in vivo

Sep. 14, 2011

Pfizer synthesizes novel MAP kinase-activated protein kinase 2 inhibitors

Sep. 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...